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Analysis of the oxidative modification of plasma and erythrocyte ghost proteins of chronic alcoholic subjects and healthy non-alcoholics has
been performed. It was found that increased levels of protein carbonyls in both plasma and erythrocyte ghosts from alcoholic subjects occurred
in comparison to the levels found in preparations from non-alcoholics. Plasma proteins from alcoholic subjects did not show evidence of cross-
linking, although plasma protein concentration and composition were changed. In alcoholic subjects who displayed no evidence of abnormal
erythrocyte morphology no cross-linking of erythrocyte ghost proteins was detectable, whereas the ghosts obtained from alcoholic subjects who
displayed morphologically abnormal erythrocytes contained cross-linked proteins. The in vitro treatment with acetaldehyde of erythrocytes from
non-alcoholics caused increased levels of protein carbonyls and cross-linking products in erythrocyte ghost preparations which were similar to
those found in severe alcoholics. It is concluded that chronic alcohol consumption can cause abnormal erythrocyte morphology and increased
erythrocyte fragility as a result of oxidation and cross-linking of erythrocyte ghost proteins. These effects can be ascribed, in part, to exposure of
erythrocytes to circulatory acetaldehyde which is a product of ethanol metabolism.
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The chronic oxidative stress in alcoholism can lead to
oxidative modification of proteins [1–3]. Such modification
occurs principally by formation of protein carbonyls [4], and it
has been shown that the levels of protein carbonyls in blood and
other tissues are increased in experimental animals treated with
ethanol [5–7].
An immediate product of ethanol metabolism is acetalde-
hyde, and unlike ethanol, this is a highly reactive and
extremely cytotoxic compound [8] which is involved in a
number of non-enzymatic modifications of proteins, including
formation of semialdehydes, mercaptosemialdehydes and⁎ Corresponding author. Tel.: +1 740 593 1744; fax: +1 740 597 2778.
E-mail address: johnsonp@ohio.edu (P. Johnson).
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doi:10.1016/j.bbadis.2006.03.003Schiff bases with consequent protein modification and
inhibition of their biological functions [9]. The chronic
administration of ethanol to experimental animals has been
shown to cause formation of acetaldehyde–protein adducts [1]
and antibodies to malondialdehyde–acetaldehyde protein
adducts [10].
The principal site for acetaldehyde production from ethanol is
in the liver, and it is known that after copious ethanol
consumption, acetaldehyde (at sub-millimolar concentrations)
and ethanol appear in the circulatory system fromwhere they can
then be taken up in peripheral tissues [11,12]. In addition to the
known toxic effects of ethanol consumption on tissues such as
muscle [13] and the nervous system [14,15], significant damage
can occur in the circulatory system itself in alcoholism,
including T-lymphocyte immunosuppression [16], platelet
function abnormalities [17,18], and abnormal erythrocyte
morphology and stability [19–21].
Fig. 1. Scanning electron micrographs of erythrocytes from a control subject and
a Group I (anemic) alcoholic. Image A shows the control subject's erythrocytes
and image B shows those of the alcoholic subject. The scale bar in each
micrograph represents 8 μm.
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damage that occurs in the circulatory system in alcoholism,
where it has a lifetime of about 3 hours [12] and can reach
concentrations of up to 550 μM [22], there is relatively little
specific recent information about the action of acetaldehyde on
blood cells and proteins [23]. The initial work on blood protein
modification by acetaldehyde [24] showed that the in vitro
treatment of isolated erythrocyte ghosts by acetaldehyde (5–
10 mM) for 2 h at 4 °C produced cross-linked proteins, and that
exposure of normal human erythrocytes to 1 mM acetaldehyde
for 2 h at 4 °C caused poikilocytosis and stomatocytosis. Later
work [25] showed that in vitro incubation of plasma,
erythrocytes and erythrocyte ghosts with 40 μM acetaldehyde
increased the protein carbonyl contents, and that this effect did
not occur with ethanol. In our more recent studies, we have
shown that erythrocytes from alcoholics have abnormal
morphology and decreased resistance to hemolytic agents [20].
A high concentration (55 mM) of acetaldehyde was found to
decrease erythrocyte resistance to hemolysis [21], but in vitro
exposure of normal human erythrocytes to 2 μM and 3.6 mM
acetaldehyde for up to 16 hours did not induce any changes in
cell morphology, vulnerability to oxidation, or elevated rates of
hemolysis [26].
In the present studies, we have examined the long term in situ
effects of pathological ethanol consumption on both plasma and
erythrocyte proteins using blood samples obtained from chronic
alcoholics. We have also investigated if the damage to
erythrocytes of alcoholics which was found in these in situ
studies could be produced by in vitro treatment of normal
erythrocytes with acetaldehyde.
2. Materials and methods
2.1. Materials
Hanks' balanced salt solution (item H4891), BSA, heparin, primary rabbit
anti-dinitrophenyl (DNP) antibodies and secondary goat anti-rabbit, Ig alkaline
phosphatase conjugate were obtained from Sigma Chemical Co., St Louis,
MO. Sodium hypochlorite was obtained from Aldrich Chemical Co,
Milwaukee, and 2,4-dinitrophenylhydrazine was purchased from Chemapol
(Czech Republic).Table 1
Clinical profiles of subjects used in the study
Parameter Control subjects (n=22) All alcoholics
Age (years) 44.0±9.9 39.3±10.5
Duration of chronic
drinking (years)a
15.3±11.0
Ethanol intake (g/d)a 250±90
Erythrocyte count (×1012/l) 4.73±0.26 4.57±0.36
% Normal erythrocytes 87.2±5.0 66.8±20.9
Hemoglobin (g/dl) 15.00±0.63 13.99±1.26
Blood protein (g/dl) 7.44±0.49 8.29±0.53b
Serum ALT (mmol/ml/h) 0.1–0.7d 0.85±0.70
Serum AST (mmol/ml/h) 0.1–0.5d 0.38±0.30
a These values were self-reported by the subjects and may not be reliable. The va
b P<0.05 in comparison to control group.
c P<0.05 in comparison to Group II alcoholics.
d Normal range quoted in Russian open medical vade-mecum.2.2. Erythrocyte sources and preparation
Blood was donated at the Mental Health Research Institute, Russian
Academy of Medical Sciences, Tomsk. Institutional approval for the use of
human subjects in this study and the prior informed consent of all donors were
obtained. Blood samples were obtained from 22 adult male donors in normal
health and from 42 adult male alcoholic patients who had abstained from alcohol
consumption for between 1 to 5 days before blood donation. All of the subjects
in the study were smokers. Heparin (25 units/ml of blood) was used to prevent
coagulation of the drawn blood and erythrocyte purification was performed as(n=42) Group I alcoholics (n=7) Group II alcoholics (n=35)
34.6±7.1 40.2±10.9
13.0±9.2 15.7±11.4
270±80 240±80
4.15±0.28b 4.66±0.31
38.3±9.6b, c 80.1±4.6b
11.97±1.13b, c 14.40±0.82
8.22±1.03 8.31±0.40b
0.94±0.44 0.83±0.75
0.62±0.47 0.33±0.23
lues for ethanol consumption were approximated to the nearest 10 ml/day.
Table 2
Protein carbonyl contents in erythrocyte ghosts and plasma of control and
alcoholic subjects
Subjects Protein carbonyl content (nmol/mg of protein)
Erythrocyte ghosts Plasma
Controls 0.131±0.096 0.089±0.007
All alcoholics 0.669±0.141a 0.410±0.032a
Group I alcoholics 0.760±0.090a 0.500±0.070a
Group II alcoholics 0.623±0.102a 0.380±0.026a
a Indicates a significant difference (all P<0.001 ) between means for the
control group (n=6) compared to all alcoholics (n=10), alcoholics with
anisocytosis and poikilocytosis (Group I, n=3), and alcoholics with no
anisocytosis or poikilocytosis (Group II, n=7).
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wash buffer.
Incubation of erythrocytes with various concentrations of acetaldehyde was
performed in HBSS at 37 °C using filled sealed vials to prevent acetaldehyde
evaporation. After incubation, the cells were collected by centrifugation at room
temperature (600×g for 10 min) and then hemolysed by osmotic shock, after
which erythrocyte ghosts were prepared [28].
2.3. Analysis of protein carbonyls and cross-linked proteins
Protein carbonyls in erythrocyte ghosts and plasma were measured
immunochemically using slot-blots after treatment of the proteins with
DNPH. For the identification of the DNPH-labeled proteins, primary anti-
dinitrophenyl (DNP) antibodies and a secondary anti-rabbit Ig alkaline
phosphatase conjugate were used. Bovine serum albumin treated with 5 mM
NaOCl for 1 hour at 25 °C was used as a standard for protein carbonyl-
containing protein [29]. Quantitative analysis of slot-blot bands (triplicate
samples) was accomplished using the OneDscan program (Scanalytics,
USA).
Proteins (20 μg total) in erythrocyte ghost and plasma preparations were
separated using SDS-PAGE with a 7.5% running gel and a 4% stacking gel, and
then visualized by staining with Coomassie Brilliant Blue [30]. Thyroglobulin
(330 kDa), phosphorylase (94 kDa), bovine serum albumin (67 kDa), ovalbumin
(43 kDa), lactate dehydrogenase (36 kDa) and carbonic anhydrase (30 kDa)
were used as molecular weight markers.Fig. 2. SDS-PAGE analyses of plasma and erythrocyte ghost proteins. Arrows sho
protein (A) and erythrocyte ghost preparations (B) from control subjects and alcoho
identities in A and B are: 1 and 2, control (healthy) subjects; 3 and 4, Group II alc
respective positions of the 52 kDa and 220 kDa bands whose levels are elevated
composition of erythrocyte ghosts from a non-alcoholic control subject is shown. S
37 °C and then analyzed as described in Materials and methods. Sample identities
treated with 11 mM (0.05%) acetaldehyde; 3, erythrocyte ghosts treated with 22 mM
acetaldehyde.2.4. Statistical analysis
The data in the tables and figures are presented as means±SD. One-way
ANOVA using the Dunnett method was performed to determine significant
differences between data sets. Data sets with P<0.05 were considered to be
significantly different.
3. Results
3.1. Clinical profiles of the donor groups
Analysis of blood samples from alcoholics revealed that 7 of
the 42 subjects were anemic as evidenced by a decreased
hemoglobin concentration and a lowered erythrocyte count
(Table 1), although no reticulocytosis was evident by light
microscopy. As shown in Table 1 and Fig. 1, these subjects also
had a large proportion of morphologically abnormal erythro-
cytes showing acanthocytosis, stomatocytosis, anisocytosis and
poikilocytosis. Accordingly, two groups of alcoholic subjects
were designated; Group I which consisted of those subjects who
had anemia and erythrocyte populations with extensive
abnormal morphology, and Group II which was comprised of
non-anemic subjects with proportions of undistorted erythro-
cytes that were not significantly different from those of the
control subjects (Table 1). Other relevant clinical parameters for
the control and alcoholic groups are shown in Table 1. Plasma
protein levels in all alcoholics and Group II alcoholics were
significantly higher than in control subjects, but although the
Group I alcoholics also showed an increase in mean protein
levels, this figure was not significantly different from the
control mean. There were also elevations above the normal
range in serum alanine aminotransferase (ALT) activities in
both Group I and Group II alcoholics and for serum aspartate
aminotransferase (AST) for Group II alcoholics compared to
control subjects, which are indicative of liver damage in the
alcoholic subjects.w the positions of molecular weight standards with Mr values in kDa. Plasma
lics were prepared and analyzed as described in Materials and methods. Sample
oholics; and 5 and 6, Group I alcoholics. Asterisks by gels A and B show the
in samples from alcoholics. In C, the effect of acetaldehyde on the protein
amples were incubated with various concentrations of acetaldehyde for 5 h at
are: 1, erythrocyte ghosts not treated with acetaldehyde; 2, erythrocyte ghosts
(0.1%) acetaldehyde; and 4, erythrocyte ghosts treated with 55 mM (0.25%)
Table 3
The effect of in vitro incubation of normal erythrocytes with acetaldehyde
Incubation time (h) Relative protein carbonyl content
1 2.82±0.05
2.5 3.59±0.08
5 6.79±0.13
Erythrocytes from control (healthy) donors were incubated in HBSS containing
55 mM (0.25%) acetaldehyde for different time periods and protein carbonyl
contents of erythrocyte ghost preparations were determined as described in
Materials and methods. Results are expressed relative to a parallel time control
without acetaldehyde. The protein carbonyl content for each incubation period
was significantly different (P<0.01, n=8 for each incubation time).
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ghosts and plasma
The results of quantitative analysis of protein carbonyl
contents in erythrocyte ghost and plasma samples from the two
groups of alcoholics and healthy donors are shown in Table 2.
These results show that erythrocyte ghost and plasma prepara-
tions from all alcoholics and from both Group I and II alcoholics
have significantly increased amounts of oxidized proteins in
comparison to control subjects. The protein carbonyl contents in
erythrocyte ghosts and plasma were higher in Group I than in
Group II alcoholic samples, although the P values for the
differences were above 0.05.
3.3. SDS-PAGE analysis of plasma and erythrocyte ghost
proteins
As shown in Fig. 2A, the plasma protein profiles of
alcoholics from both groups showed no evidence of higher
molecular weight components in comparison to the control
group, and the only difference between the alcoholic and control
samples was an increased relative amount of a 52 kDa protein
which migrates in front of the predominant albumin band. It
appears unlikely that this band is a cross-linked product caused
by ethanol intoxication as it was present in the plasma of control
subjects and because there were no major changes in the lower
molecular weight bands of the plasma samples of the alcoholics.
In contrast, the erythrocyte ghost profiles of the Group I and
II alcoholics (Fig. 2B) showed increases in the amounts of a
220 kDa protein band in comparison to the control, and the
Group I alcoholics also showed increased amounts of high
molecular weight proteins at the top of the running gel and of
very high molecular weight protein at the top of the loading gel.
A further difference in the erythrocyte ghost profiles was that
Group I alcoholic samples had lower relative levels of protein
bands below 94 kDa in comparison to the Group II alcoholic
and control samples, suggesting that in alcoholics the increases
in the 220 kDa band and other higher molecular weight proteins
are cross-linked products derived from the lower molecular
weight components.
3.4. Analysis of the in vitro effects of acetaldehyde on proteins
of erythrocyte ghosts
Because we found changes in both oxidized protein levels
and cross-linking effects in the erythrocytes of Group I
alcoholics, experiments were performed to determine if in
vitro acetaldehyde treatment could cause these effects in
erythrocytes of control subjects.
In experiments to determine oxidized protein levels,
incubation of normal erythrocytes with 55 mM (0.25%)
acetaldehyde was performed for 1, 2.5 and 5 h, after which
protein carbonyl contents were measured by the immunochem-
ical slot-blot procedure. As shown in Table 3, protein carbonyl
levels in the ghosts were significantly increased in a time-
dependent manner at this non-physiological level of acetalde-
hyde, suggesting that lower chronic in vivo levels of circulatoryacetaldehyde could also give rise to this phenomenon over a
longer period of time.
When proteins of acetaldehyde-treated erythrocyte ghosts
were analyzed by SDS-PAGE (Fig. 2C), the acetaldehyde
treatment was found to result in dose-dependent increases in the
amounts of high molecular weight proteins at about 220 kDa, at
the interface of the loading and running gels and at the top of the
loading gel, a pattern which was similar to that seen in the
erythrocyte ghosts from Group I alcoholics.
4. Discussion
The clinical parameters of the alcoholic subjects used in this
study reveal that there are changes in blood chemistry indicative
of anemia, abnormal erythrocyte morphology and possible liver
damage, although other parameters which are affected in
alcoholism such as MCV [31] and erythrocyte osmotic stability
[32] were not assessed. We also found that there was a
significant increase in plasma protein concentration in the
Group II (but not the Group I) alcoholics. It is possible that this
increase may be the result of dehydration caused by ethanol
inhibition of anti-diuretic hormone effects, even though the
alcoholic subjects were abstinent for at least one day before
blood sampling. An increased amount of a plasma protein of
approximately 52 kDa was seen in the alcoholics which does
not appear to be a cross-linked product. This change may
represent a difference in protein synthesis levels in the alcoholic
subjects, and may also contribute to the elevation of plasma
protein concentration in the alcoholics.
These studies on chronic alcoholics clearly show that there is
an increase in oxidized proteins in their plasma and erythrocyte
membranes, but only an increase in higher molecular weight
proteins in their erythrocyte membranes. The higher molecular
weight proteins appears to result from cross-linking reactions,
and not from de novo protein synthesis, as very similar patterns
were observed when erythrocyte ghosts prepared from non-
alcoholic donors were subjected to in vitro exposure to
acetaldehyde. Increases in protein damage were related to the
severity of the alcoholism as protein cross-linking was observed
only in erythrocytes from Group I alcoholics whose erythro-
cytes were morphologically abnormal. A further indication that
the degree of protein damage is related to the extent of the
alcoholism was that both Group I erythrocyte ghost and plasma
mean protein carbonyl levels were elevated over the Group II
562 O.V. Tyulina et al. / Biochimica et Biophysica Acta 1762 (2006) 558–563values, even though the differences did not appear to be
statistically significant. In this case, it is possible that the
relatively small number of alcoholic subjects used for these
analyses could account for the P values for these differences
being larger than 0.05.
Our results confirm the findings of previous in vitro and in
situ studies [6,7,24,25] in which it was shown that oxidation
and cross-linking of proteins is a consequence of alcohol
consumption or acetaldehyde treatment. Furthermore, we have
been able to demonstrate that some of the protein oxidation
and cross-linking changes in erythrocytes from alcoholics
could be produced under in vitro conditions when erythrocytes
from non-alcoholics were exposed to acetaldehyde. These
findings support the concept that oxidative damage in the
circulatory system and peripheral tissues may result from the
chronic circulation of acetaldehyde at low concentrations as a
result of prolonged high levels of ethanol metabolism to
acetaldehyde in the liver [15,33].
A further important finding of this work was that formation
of oxidized and cross-linked protein in erythrocyte ghosts
from alcoholics was seen only in alcoholic subjects who
displayed anemia and extensive erythrocyte abnormal mor-
phology. In contrast, in those alcoholics who were not anemic
and showed no significant differences from control subjects in
terms of abnormal cell morphology only protein oxidation was
observed. These results indicate that the abnormal erythrocyte
morphology of alcoholism in Group I alcoholics may be
related to protein cross-linking at the membrane–cytosol
interface of the cell, and that this phenomenon is dependent on
ethanol dosage. In those cases (Group II alcoholics) where no
increased abnormal morphology is seen, although acetalde-
hyde must be able to penetrate the erythrocyte and cause some
oxidative damage to proteins, this level of damage (approx-
imately 80% of that seen in Group I alcoholics) does not lead
to detectable protein cross-linking. It is possible that under
such lower loads of acetaldehyde, this compound can be
oxidized to acetate by erythrocyte aldehyde dehydrogenase at
a rate which limits protein damage, whereas in more severe
alcoholism, the capacity of this enzyme to degrade acetalde-
hyde is exceeded, permitting further oxidative damage to
proteins which leads to cross-linking.
Although erythrocytes from severe alcoholics were found
to contain oxidized cross-linked proteins, no evidence was
found for cross-linking of plasma proteins from these subjects,
although protein oxidation occurred. There are several
possible explanations as to why the damage to plasma
proteins is apparently less severe than that for erythrocyte
proteins. One possibility is that the much shorter half-lives
[34–36] of plasma proteins in comparison to those of
erythrocyte proteins would prevent the cumulative damage
leading to cross-linking that occurs in the erythrocyte. Another
factor may be that the much higher protein concentration
inside the erythrocyte than in plasma would favor protein
cross-linking. A further issue may be that the higher
concentrations of free radicals within the erythrocyte [37]
could favor more protein cross-link formation. It has also been
suggested that erythrocyte catalase can oxidize ethanol toacetaldehyde, thereby increasing the concentration of acetal-
dehyde within the erythrocyte to levels greater than that in the
plasma [38,39]. Although this remains a possibility as
erythrocyte acetaldehyde levels have been reported to be
about 50% higher than those in plasma [40], our previous
studies [26] have failed to detect any significant in vitro
metabolism of ethanol in erythrocytes which suggests that
intracellular generation of acetaldehyde from ethanol is
probably not responsible for the elevated levels of protein
damage observed in severe alcoholics.
In summary, our studies have shown that chronic alcohol
consumption which causes abnormal erythrocyte morphology is
associated with oxidation and cross-linking of erythrocyte
membrane proteins. These changes could also be produced by
in vitro exposure to acetaldehyde of erythrocyte ghost prepara-
tions from subjects who were not alcoholics. The conclusion
from these findings is that acetaldehyde is responsible, at least in
part, for erythrocyte and plasma protein damage in vivo, and that
the protein cross-linking effects in erythrocytes cause abnormal
morphology of the erythrocytes and decrease their normal life
span. Current studies in our laboratories are in progress to
determine if other blood cell types (leucocytes and platelets) also
manifest similar types of damage in alcoholism and to
investigate the effects of such modifications on the stability
and function of these cell types.
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